These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19487260)

  • 1. Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis.
    Schoindre Y; Meune C; Dinh-Xuan AT; Avouac J; Kahan A; Allanore Y
    J Rheumatol; 2009 Jul; 36(7):1481-5. PubMed ID: 19487260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between left ventricular diastolic dysfunction and six minute walk test in patients with systemic sclerosis.
    Akdogan A; Kaya EB; Sahin A; Okutucu S; Yakut E; Kalyoncu U; Aksoy H; Karadag O; Calguneri M; Tokgozoglu L; Kiraz S; Ertenli I
    Int J Rheum Dis; 2011 Oct; 14(4):379-83. PubMed ID: 22004236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis.
    Deuschle K; Weinert K; Becker MO; Backhaus M; Huscher D; Riemekasten G
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S53-9. PubMed ID: 21586219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.
    Beretta L; Santaniello A; Lemos A; Masciocchi M; Scorza R
    Rheumatology (Oxford); 2007 Feb; 46(2):296-301. PubMed ID: 16877463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percent predicted value for the 6-minute walk test: using norm-referenced equations to characterize severity in persons with CHF.
    Balashov K; Feldman DE; Savard S; Houde S; Frenette M; Ducharme A; Giannetti N; Michel C; Pilote L
    J Card Fail; 2008 Feb; 14(1):75-81. PubMed ID: 18226776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical determinants of the 6-Minute Walk Test in bronchiectasis.
    Lee AL; Button BM; Ellis S; Stirling R; Wilson JW; Holland AE; Denehy L
    Respir Med; 2009 May; 103(5):780-5. PubMed ID: 19070473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights.
    Guazzi M; Dickstein K; Vicenzi M; Arena R
    Circ Heart Fail; 2009 Nov; 2(6):549-55. PubMed ID: 19919979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-minute walk test in patients with Down syndrome: validity and reproducibility.
    Vis JC; Thoonsen H; Duffels MG; de Bruin-Bon RA; Huisman SA; van Dijk AP; Hoendermis ES; Berger RM; Bouma BJ; Mulder BJ
    Arch Phys Med Rehabil; 2009 Aug; 90(8):1423-7. PubMed ID: 19651279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease.
    Wilsher M; Good N; Hopkins R; Young P; Milne D; Gibson A; Suppiah R; Ly J; Doughty R; Dalbeth N
    Respirology; 2012 May; 17(4):647-52. PubMed ID: 22256786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with the 6-minute walk distance in patients with systemic sclerosis.
    Sanges S; Giovannelli J; Sobanski V; Morell-Dubois S; Maillard H; Lambert M; Podevin C; Lamblin N; De Groote P; Bervar JF; Perez T; Matran R; Rémy-Jardin M; Hatron PY; Hachulla É; Launay D
    Arthritis Res Ther; 2017 Dec; 19(1):279. PubMed ID: 29246248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 6-minute walk test in scleroderma--how measuring everything measures nothing.
    Impens AJ; Wangkaew S; Seibold JR
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v68-9. PubMed ID: 18784152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-minute walk test in obese children and adolescents: reproducibility and validity.
    Morinder G; Mattsson E; Sollander C; Marcus C; Larsson UE
    Physiother Res Int; 2009 Jun; 14(2):91-104. PubMed ID: 19003813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-minute walk test in patients with permanent cardiac pacemakers.
    Pereira de Sousa LA; Britto RR; Ribeiro AL; Baracho SM; da Costa Val Barros V; Carvalho VT; Parreira VF
    J Cardiopulm Rehabil Prev; 2008; 28(4):253-7. PubMed ID: 18628656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.
    Vandecasteele E; Melsens K; De Keyser F; De Pauw M; Deschepper E; Decuman S; Piette Y; Thevissen K; Brusselle G; Smith V
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):95-101. PubMed ID: 30183593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating maximum work rate during incremental cycle ergometry testing from six-minute walk distance in patients with chronic obstructive pulmonary disease.
    Hill K; Jenkins SC; Cecins N; Philippe DL; Hillman DR; Eastwood PR
    Arch Phys Med Rehabil; 2008 Sep; 89(9):1782-7. PubMed ID: 18760164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension.
    Gomberg-Maitland M; Huo D; Benza RL; McLaughlin VV; Tapson VF; Barst RJ
    J Heart Lung Transplant; 2007 Jul; 26(7):732-8. PubMed ID: 17613405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility and Utility of the 6-minute Walk Test in Systemic Sclerosis.
    Pugnet G; Marjanovic Z; Deligny C; Boussardon K; Benzidia I; Puyade M; Lansiaux P; Vandecasteele E; Smith V; Farge D
    J Rheumatol; 2018 Aug; 45(9):1273-1280. PubMed ID: 29961695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement.
    de Oliveira NC; dos Santos Sabbag LM; Ueno LM; de Souza RB; Borges CL; de Sá Pinto AL; Lima FR
    Scand J Rheumatol; 2007; 36(6):458-61. PubMed ID: 18092268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term health-related quality of life and walking capacity of lung recipients with and without bronchiolitis obliterans syndrome.
    Gerbase MW; Soccal PM; Spiliopoulos A; Nicod LP; Rochat T
    J Heart Lung Transplant; 2008 Aug; 27(8):898-904. PubMed ID: 18656804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.